Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
IRX-010 by ImmunoRx Pharma for Inflammation: Likelihood of Approval
IRX-010 is under clinical development by ImmunoRx Pharma and currently in Phase I for Inflammation. According to GlobalData, Phase I...